Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics

17-03-2024 | Hysteroscopy | Review

Current practice with operative hysteroscopy for fertility preservation in endometrial cancer and endometrial premalignancies

Authors: Esra Bilir, Joanna Kacperczyk-Bartnik, Nicolò Bizzarri, İlker Kahramanoğlu

Published in: Archives of Gynecology and Obstetrics

Login to get access

Abstract

Purpose

The primary aim was to analyze the current practices on the use of operative hysteroscopy for preserving fertility in patients diagnosed with endometrial cancer and premalignancies. Our secondary objectives included investigating medical therapy and analyzing reported pregnancy-related outcomes subsequent to fertility preservation procedures.

Methods

We performed a semi-systematic literature review on PubMed, employing pertinent terms related to hysteroscopy, fertility preservation, and endometrial cancer and premalignancies. Patients undergoing operative hysteroscopy with or without following medical treatment were included. We adhered to the PRISMA 2020 statement and utilized Covidence software to manage our systematic review. We performed a pooled analysis on various outcomes.

Results

Our final analysis included 15 studies evaluating 458 patients, where 238 (52.0%) were diagnosed with endometrial cancer, and 220 (48.0%) had endometrial premalignancies. With 146 pregnancies in our study, the overall pregnancy rate was 31.9%. Among these, 97 resulted in live births, accounting for 66.4% of the reported pregnancies. In terms of medical treatment, various forms of progestins were reported. Complications or adverse effects related to operative hysteroscopy were not reported in more than half of the studies. Among those studies that did report them, no complications nor adverse effects were documented. After hysteroscopic resection, complete response to medical treatment has been reported in 65.5% of the overall cases.

Conclusion

Our review sheds light on the contemporary landscape of operative hysteroscopy for fertility preservation in endometrial cancer and premalignancies. Future studies should include the integration of molecular classification into fertility-preserving management of endometrial malignancies to offer a more personalized and precise strategy.
Literature
1.
Guo F, Levine L, Berenson A (2021) Trends in the incidence of endometrial cancer among young women in the United States, 2001 to 2017. J Clin Oncol 39(15_suppl):5578CrossRef
2.
Bulutay P et al (2022) Epidermal growth factor receptor-mutated lung adenocarcinoma diagnosed from endometrial polyp metastasis: a case report and literature review. Turk J Obstet Gynecol 19(1):81–86CrossRefPubMedPubMedCentral
3.
Rodolakis A et al (2023) ESGO/ESHRE/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Int J Gynecol Cancer 33(2):208–222CrossRefPubMed
4.
Mazzon I et al (2010) Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril 93(4):1286–1289CrossRefPubMed
5.
Bilir E, Kahramanoğlu İ (2023) The role of hysteroscopy in fertility preservation in endometrial cancer and atypical endometrial hyperplasia: a semi-systematic literature review. Arch Gynecol Obstet 308(4):1113–1126CrossRefPubMed
6.
7.
8.
Yang HC, Liu JC, Liu FS (2019) Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy. Taiwan J Obstet Gynecol 58(1):90–93CrossRefPubMed
9.
Gonthier C et al (2014) Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer. Gynecol Oncol 133(1):33–37CrossRefPubMed
10.
Falcone F et al (2017) Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer. J Gynecol Oncol 28(1):e2CrossRefPubMed
11.
Wang F et al (2017) Fertility preserved hysteroscopic approach for the treatment of stage IA endometrioid carcinoma. Int J Gynecol Cancer 27(9):1919–1925CrossRefPubMedPubMedCentral
12.
Parlakgumus HA et al (2014) Fertility outcomes of patients with early stage endometrial carcinoma. J Obstet Gynaecol Res 40(1):102–108CrossRefPubMed
13.
Atallah D et al (2021) The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women. Arch Gynecol Obstet 304(5):1299–1305CrossRefPubMed
14.
Arendas K et al (2015) Hysteroscopic resection in the management of early-stage endometrial cancer: report of 2 cases and review of the literature. J Minim Invasive Gynecol 22(1):34–39CrossRefPubMed
15.
Laurelli G et al (2015) Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature. Eur J Obstet Gynecol Reprod Biol 195:61–66CrossRefPubMed
16.
Casadio P et al (2018) Fertility-sparing treatment of endometrial cancer with initial infiltration of myometrium by resectoscopic surgery: a pilot study. Oncologist 23(4):478–480CrossRefPubMedPubMedCentral
17.
Falcone F et al (2019) Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series. Eur J Obstet Gynecol Reprod Biol 240:220–225CrossRefPubMed
18.
De Marzi P et al (2015) Hysteroscopic resection in fertility-sparing surgery for atypical hyperplasia and endometrial cancer: safety and efficacy. J Minim Invasive Gynecol 22(7):1178–1182CrossRefPubMed
19.
Ricciardi E et al (2012) Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view. Eur Rev Med Pharmacol Sci 16(14):1934–1937PubMed
20.
Kahramanoglu I (2021) Hysteroscopic treatments for endometrial malignancies and premalignancies: state of the art. Minim Invasive Ther Allied Technol 30(5):272–277CrossRefPubMed
21.
Zhang Q et al (2017) Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia. Oncotarget 8(34):57642–57653CrossRefPubMedPubMedCentral
22.
Vitale SG et al (2021) Innovations in hysteroscopic surgery: expanding the meaning of “in-office.” Minim Invasive Ther Allied Technol 30(3):125–132CrossRefPubMed
23.
Vitale SG et al (2021) Hysteroscopic endometrial biopsy: from indications to instrumentation and techniques. A call to action. Minim Invasive Ther Allied Technol 30(5):251–262CrossRefPubMed
24.
Vitale SG et al (2023) Diode laser use in hysteroscopic surgery: current status and future perspectives. Minim Invasive Ther Allied Technol 32(6):275–284CrossRefPubMed
25.
Berek JS et al (2023) FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet 162(2):383–394CrossRefPubMed
26.
Matoba Y et al (2019) Atypical Polypoid adenomyoma treated by hysteroscopy with photodynamic diagnosis using 5-aminolevulinic acid: a case report. Photodiagnosis Photodyn Ther 27:295–297CrossRefPubMed
27.
Yang B et al (2019) Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer. Gynecol Oncol 153(1):55–62CrossRefPubMed
28.
Ayhan A, Tohma YA, Tunc M (2020) Fertility preservation in early-stage endometrial cancer and endometrial intraepithelial neoplasia: a single-center experience. Taiwan J Obstet Gynecol 59(3):415–419CrossRefPubMed
29.
Xu Z et al (2020) Efficacy and prognosis of fertility-preserved hysteroscopic surgery combined with progesterone in the treatment of complex endometrial hyperplasia and early endometrial carcinoma. J BUON 25(3):1525–1533PubMed
Metadata
Title
Current practice with operative hysteroscopy for fertility preservation in endometrial cancer and endometrial premalignancies
Authors
Esra Bilir
Joanna Kacperczyk-Bartnik
Nicolò Bizzarri
İlker Kahramanoğlu
Publication date
17-03-2024
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-024-07463-9